These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
769 related items for PubMed ID: 11391738
1. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Ahlskog JE, Muenter MD. Mov Disord; 2001 May; 16(3):448-58. PubMed ID: 11391738 [Abstract] [Full Text] [Related]
2. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa. Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G. Brain; 2014 Oct; 137(Pt 10):2731-42. PubMed ID: 25034897 [Abstract] [Full Text] [Related]
3. Motor complications in an incident Parkinson's disease cohort. Scott NW, Macleod AD, Counsell CE. Eur J Neurol; 2016 Feb; 23(2):304-12. PubMed ID: 26074125 [Abstract] [Full Text] [Related]
4. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy. Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A. Parkinsonism Relat Disord; 2005 May; 11(3):151-5. PubMed ID: 15823479 [Abstract] [Full Text] [Related]
5. Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease. Haaxma CA, Horstink MW, Zijlmans JC, Lemmens WA, Bloem BR, Borm GF. J Parkinsons Dis; 2015 May; 5(4):847-53. PubMed ID: 26444087 [Abstract] [Full Text] [Related]
6. Complex dyskinesias in Parkinson patients on levodopa/carbidopa intestinal gel. Marano M, Naranian T, di Biase L, Di Santo A, Poon YY, Arca R, Cossu G, Marano P, Di Lazzaro V, Fasano A. Parkinsonism Relat Disord; 2019 Dec; 69():140-146. PubMed ID: 31759188 [Abstract] [Full Text] [Related]
7. Risk and course of motor complications in a population-based incident Parkinson's disease cohort. Bjornestad A, Forsaa EB, Pedersen KF, Tysnes OB, Larsen JP, Alves G. Parkinsonism Relat Disord; 2016 Jan; 22():48-53. PubMed ID: 26585090 [Abstract] [Full Text] [Related]
8. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Schrag A, Quinn N. Brain; 2000 Nov; 123 ( Pt 11)():2297-305. PubMed ID: 11050029 [Abstract] [Full Text] [Related]
11. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Kostic V, Przedborski S, Flaster E, Sternic N. Neurology; 1991 Feb; 41(2 ( Pt 1)):202-5. PubMed ID: 1992362 [Abstract] [Full Text] [Related]
13. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study. Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, PKDS009 Study Group. CNS Drugs; 2004 Feb; 18(11):733-46. PubMed ID: 15330687 [Abstract] [Full Text] [Related]
16. Factors associated with motor complications in Parkinson's disease. Kadastik-Eerme L, Taba N, Asser T, Taba P. Brain Behav; 2017 Oct; 7(10):e00837. PubMed ID: 29075578 [Abstract] [Full Text] [Related]
18. Predictors of motor complications in early Parkinson's disease: A prospective cohort study. Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, Klein JC, Ben-Shlomo Y, Hu MT. Mov Disord; 2019 Aug; 34(8):1174-1183. PubMed ID: 31283854 [Abstract] [Full Text] [Related]
19. The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications. Kostić VS, Marinković J, Svetel M, Stefanova E, Przedborski S. Eur J Neurol; 2002 Jan; 9(1):9-14. PubMed ID: 11784369 [Abstract] [Full Text] [Related]